91
Views
93
CrossRef citations to date
0
Altmetric
Article

Aurora-A Phosphorylates, Activates, and Relocalizes the Small GTPase RalA

, , , , , & show all
Pages 508-523 | Received 09 Jun 2008, Accepted 26 Oct 2009, Published online: 20 Mar 2023
 

Abstract

The small GTPase Ras, which transmits extracellular signals to the cell, and the kinase Aurora-A, which promotes proper mitosis, can both be inappropriately activated in human tumors. Here, we show that Aurora-A in conjunction with oncogenic Ras enhances transformed cell growth. Furthermore, such transformation and in some cases also tumorigenesis depend upon S194 of RalA, a known Aurora-A phosphorylation site. Aurora-A promotes not only RalA activation but also translocation from the plasma membrane and activation of the effector protein RalBP1. Taken together, these data suggest that Aurora-A may converge upon oncogenic Ras signaling through RalA.

Supplemental material for this article may be found at http://mcb.asm.org/.

We thank Mike White for plasmids pMT3-mycRalBP1 and pcDNA3-mycSec5.

This work is supported by NIH grants CA94184 and CA126903 (C.M.C.), CA42978 and CA67771 (C.J.D. and A.D.C.), and CA109550 (A.D.C.). C.M.C. is a Leukemia and Lymphoma Scholar, D.F.K. is a Leukemia and Lymphoma Fellow, and K.-H.L. and B.B.A. were Department of Defense Breast Cancer Research Predoctoral Scholars. D.C.B. is supported by an NIH T32 Training Fellowship.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.